Division of Respiratory Medicine, Research Institute, Hospital for Sick Children, Toronto, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):220-224. doi: 10.1089/jamp.2024.0012. Epub 2024 Aug 30.
Preliminary data in a randomly selected pediatric cohort study in 8-year-olds suggested a rate of positivity to a methacholine challenge test that was unexpectedly high, roughly 30%. The current recommendation for a negative methacholine test is a 20% decrease in the forced expiratory volume in one second at a dose greater than 400 μg. This was derived from studies in adults using the obsolete English Wright nebulizer. One explanation for the high incidence of positivity in the study in 8-year-olds could be that children deposit more methacholine on a μg/kg basis than adults, due to differences in their breathing patterns. The purpose of this study was to determine if pediatric breathing patterns could result in a higher dose of methacholine depositing in the lungs of children based on μg/kg body weight compared with adults. An AeroEclipse Breath Actuated nebulizer delivered methacholine aerosol, generated from a 16 mg/mL solution, for one minute, using age-appropriate breathing patterns for a 70 kg adult and a 30 and 50 kg child produced by a breathing simulator. Predicted lung deposition was calculated from the collected dose of methacholine on a filter placed at the nebulizer outport, multiplied by the fraction of the aerosol mass contained in particles ≤5 μm. The dose of methacholine on the inspiratory filter was assayed by high performance liquid chromatography (HPLC). Particle size was measured using laser diffraction technology. The mean (95% confidence intervals) predicted pulmonary dose of methacholine was 46.1 (45.4, 46.8), 48.6 (45.3, 51.9), and 36.1 (34.2, 37.9) μg/kg body weight for the 30 kg child, 50 kg child, and 70 kg adult, respectively. On a μg/kg body weight, the predicted pulmonary dose of methacholine was greater with the pediatric breathing patterns than with the adult pattern.
在一项针对 8 岁儿童的随机选择的儿科队列研究中,初步数据显示,乙酰甲胆碱挑战测试的阳性率高得令人意外,约为 30%。目前对于乙酰甲胆碱检测呈阴性的建议是,在剂量大于 400μg 时,一秒用力呼气量(FEV1)下降 20%。这一建议源自使用过时的英国 Wright 喷雾器的成人研究。8 岁儿童研究中阳性率高的一个解释可能是,由于呼吸模式的不同,儿童每公斤体重沉积的乙酰甲胆碱比成人多。这项研究的目的是确定儿童的呼吸模式是否会导致儿童肺部沉积的乙酰甲胆碱剂量高于成人,以每公斤体重微克为单位。AeroEclipse 呼吸驱动喷雾器以μg/kg 体重为单位,输送乙酰甲胆碱气溶胶,持续一分钟,使用适合 70 公斤成人和由呼吸模拟器产生的 30 公斤和 50 公斤儿童的年龄适当的呼吸模式。从放置在喷雾器出气口处的过滤器上收集的乙酰甲胆碱剂量中计算预测的肺部沉积量,乘以气溶胶质量中包含的小于或等于 5μm 的颗粒分数。将乙酰甲胆碱在吸气过滤器上的剂量通过高效液相色谱法(HPLC)进行测定。使用激光衍射技术测量粒径。预测的儿童肺部乙酰甲胆碱剂量的平均值(95%置信区间)分别为 30 公斤儿童、50 公斤儿童和 70 公斤成人的 46.1(45.4,46.8)、48.6(45.3,51.9)和 36.1(34.2,37.9)μg/kg 体重。以μg/kg 体重为单位,儿科呼吸模式预测的肺部乙酰甲胆碱剂量大于成人模式。